|

Micro-UltraSound In Cancer - Active Surveillance

RECRUITINGN/ASponsored by University of Alberta
Actively Recruiting
PhaseN/A
SponsorUniversity of Alberta
Started2022-11-30
Est. completion2025-12-31
Eligibility
Age18 Years+
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05558241

Summary

This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.

Eligibility

Age: 18 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Adult men with Gleason Grade Group 1 prostate cancer managed by active surveillance who require a confirmatory prostate biopsy

Exclusion Criteria:

* Men who cannot undergo a prostate MRI
* Men who cannot undergo a prostate biopsy

Conditions2

CancerProstate Cancer

Locations1 site

University of California Los Angeles, Department of Urology
Los Angeles, California, 90095
Wayne Brisbane, MD

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.